An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage

Cited by (1,002)

Items 401–500 of 1,002

1. Are liquid biopsies a surrogate for tissue EGFR testing?
   Jonathan Wade Goldman, Zorawar Singh Noor, Jordi Remón, Benjamin Besse, Nitzan Rosenfeld · 2017 · Annals of Oncology
2. Combinatorial Probes for High‐Throughput Electrochemical Analysis of Circulating Nucleic Acids in Clinical Samples
   Jagotamoy Das, Ivaylo Ivanov, Tina Saberi Safaei, Edward Hartley Sargent, Shana O. Kelley · 2018 · Angewandte Chemie International Edition
3. Circulating tumor DNA and radiological tumor volume identify patients at risk for relapse with resected, early-stage non-small-cell lung cancer
   Hai Thanh Tran, Simon Heeke, Sheeba J. Sujit, Natalie I. Vokes, J. Zhang, Muhammad Aminu, Vincent K. L. Lam, Ara Asadur Vaporciyan, Stephen G. Swisher, Myrna C.B. Godoy et al. · 2023 · Annals of Oncology
4. Elimination of unaltered DNA in mixed clinical samples via nuclease-assisted minor-allele enrichment
   Chen Song, Yibin Liu, Rachel E. Fontana, Alexander Makrigiorgos, Harvey J. Mamon, Matthew H. Kulke, Gerassimos Mike Makrigiorgos · 2016 · Nucleic Acids Research
5. Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer
   Villaflor, Victoria, Won, Brian, Nagy, Rebecca, Banks, Kimberly, Lanman, Richard B., Talasaz, AmirAli, Salgia, Ravi · 2016 · Oncotarget
6. Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
   Xianliang Cheng, Lei Zhang, Yajuan Chen, Chen Qing · 2017 · Journal of Ovarian Research
7. Urine cell-free DNA multi-omics to detect MRD and predict survival in bladder cancer patients
   Pradeep S. Chauhan, Alexander L. Shiang, Irfan Alahi, R. Taylor Sundby, Wenjia Feng, Bilge Gungoren, Cayce Nawaf, Kevin Yi Chen, Ramandeep K. Babbra, Peter K. W. Harris et al. · 2023 · npj Precision Oncology
8. Emerging circulating biomarkers in glioblastoma: promises and challenges
   Mehdi Touat, Alberto Durán-Peña, Agustí Alentorn, Ludovic Lacroix, Christophe Massard, Ahmed Idbaïh · 2015 · Expert Review of Molecular Diagnostics
9. Highly personalized detection of minimal Ewing sarcoma disease burden from plasma tumor DNA
   Masanori Hayashi, David T. W. Chu, Christian Frederick Meyer, Nicolas Jose Llosa, Gregory McCarty, Carol D. Morris, Adam Scott Levin, Jean‐Paul Wolinsky, Catherine Michelle Albert, Diana A. Steppan et al. · 2016 · Cancer
10. Cytology Smears in the Era of Molecular Biomarkers in Non–Small Cell Lung Cancer: Doing More With Less
    María D. Lozano, Jose Ignacio Echeveste, Marta Abengozar‐Muela, Luis D. Mejías, Miguel Angel Idoate, Alfonso Calvo, Carlos E. de Andrea · 2018 · Archives of Pathology & Laboratory Medicine
11. Bile cell‑free DNA as a novel and powerful liquid biopsy for detecting somatic variants in biliary tract cancer
    Ningjia Shen, Dadong Zhang, Lei Yin, Yinghe Qiu, Jian Liu, Wenlong Yu, Xiaohui Fu, Bin Zhu, Xiaoya Xu, Anqi Duan et al. · 2019 · Oncology Reports
12. Circulating Tumor DNA Predicts the Response and Prognosis in Patients With Early Breast Cancer Receiving Neoadjuvant Chemotherapy
    Shunying Li, Hongna Lai, Jieqiong Liu, Yujie Liu, Liang Jin, Yudong Li, Fengtao Liu, Yuhua Gong, Yanfang Guan, Xin Yi et al. · 2020 · JCO Precision Oncology
13. The present and future of measurable residual disease testing in acute myeloid leukemia
    James Stewart Blachly, Roland B. Walter, Christopher Simon Hourigan · 2022 · Haematologica
14. Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma
    Mark J. Roschewski, Louis M. Staudt, Wyndham Hopkins Wilson · 2016 · Blood
15. Blood-based tumor biomarkers in lung cancer for detection and treatment
    Hirva Mansurali Mamdani, Shahid Sattar Ahmed, Samantha Ann Armstrong, Tony S.K. Mok, Shadia Ibrahim Jalal · 2017 · Translational Lung Cancer Research
16. Assessment of circulating tumor DNA in pediatric solid tumors: The promise of liquid biopsies
    Abbou, Samuel D., Shulman, David S., DuBois, Steven G., Crompton, Brian D. · 2019 · Pediatric Blood & Cancer
17. Circulating Tumor DNA Detection by Digital-Droplet PCR in Pancreatic Ductal Adenocarcinoma: A Systematic Review
    Marisol Huerta, Susana Roselló, Luis Sabater-Orti, Ana Ferrer, Noelia Tarazona, Desamparados Roda, Valentina Gambardella, Clara Alfaro‐Cervelló, Marina Garcés‐Albir, Andrès M.R. Cervantes et al. · 2021 · Cancers
18. Targeted replacement of full-length CFTR in human airway stem cells by CRISPR-Cas9 for pan-mutation correction in the endogenous locus
    Sriram Vaidyanathan, Ron Baik, Lü Chen, Dawn T. Bravo, Carlos Jose Suarez, Shayda M. Abazari, Ameen Abdulla Salahudeen, Amanda M. Dudek, Christopher A. Teran, Timothy Davis et al. · 2021 · Molecular Therapy
19. Cell-free DNA captures tumor heterogeneity and driver alterations in rapid autopsies with pre-treated metastatic cancer
    Bernard Pereira, Christopher T. Chen, Lipika Goyal, Charlotte S. Walmsley, Christopher J. Pinto, Islam Baiev, Read Allen, Laura E. Henderson, Supriya K. Saha, Stephanie Reyes et al. · 2021 · Nature Communications
20. Sonobiopsy for minimally invasive, spatiotemporally-controlled, and sensitive detection of glioblastoma-derived circulating tumor DNA
    Christopher Pham Pacia, Jinyun Yuan, Yimei Yue, Lu Xu, Arash Nazeri, Rupen R. Desai, H. Michael Gach, Xiaowei Wang, Michael Talcott, Aadel A. Chaudhuri et al. · 2021 · Theranostics
21. Paper-Based Strips for the Electrochemical Detection of Single and Double Stranded DNA
    Stefano Cinti, Elena Proietti, Federica Casotto, Danila Moscone, Fabiana Arduini · 2018 · Analytical Chemistry
22. Selective KRAS G12C inhibitors in non-small cell lung cancer: chemistry, concurrent pathway alterations, and clinical outcomes
    Palma, Gabriela, Khurshid, Faisal, Lu, Kevin, Woodward, Brian, Husain, Hatim · 2021 · npj Precision Oncology
23. Detecting cancer by monitoring circulating tumor DNA
    Paul T. Spellman, Joe W. Gray · 2014 · Nature Medicine
24. A High-Performing Plasma Metabolite Panel for Early-Stage Lung Cancer Detection
    Lun Zhang, Jiamin Zheng, Rashid Ahmed, Guoyu Huang, Jennifer Reid, Rupasri Mandal, Andrew Maksymuik, DANIEL S. SITAR, Paramjit S. Tappia, Bram Ramjiawan et al. · 2020 · Cancers
25. Integrative analysis of multi-omics data for liquid biopsy
    Geng Chen, Jing Zhang, Qiaoting Fu, Valérie Taly, Fei Tan · 2022 · British Journal of Cancer
26. Potential clinical utility of liquid biopsy in early-stage non-small cell lung cancer
    Haifeng Shen, Yichen Jin, Heng Zhao, Manqi Wu, Kai Zhang, Zihan Wei, Xin Wang, Ziyang Wang, Yun Li, Fan Yang et al. · 2022 · BMC Medicine
27. Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer
    Vincenza Caputo, Fortunato Ciardiello, Carminia Maria Della Corte, Giulia Martini, Teresa Troiani, Stefania Napolitano · 2023 · Exploration of Targeted Anti-tumor Therapy
28. Dual Tumor Exosome Biomarker Co-recognitions Based Nanoliquid Biopsy for the Accurate Early Diagnosis of Pancreatic Cancer
    Zhiguo Yu, Yang� Yang, Wenming Fang, Ping Hu, Yingbin Liu, Jianlin Shi · 2023 · ACS Nano
29. Liquid biopsy in lymphoma
    Davide Rossi, Valeria Spina, Alessio Bruscaggin, Gianluca Gaïdano · 2019 · Haematologica
30. Translational Application of Circulating DNA in Oncology: Review of the Last Decades Achievements
    Н. О. Туаева, Luca Falzone, Yuri B. Porozov, Alexander E. Nosyrev, В. М. Трухан, Leda Kovatsi, Demetrios A. Spandidos, Nikolaos Drakoulis, Alexandra M. Kalogeraki, Charalampos Mamoulakis et al. · 2019 · Cells
31. cfDNA Sequencing: Technological Approaches and Bioinformatic Issues
    E. Bohers, P. Viailly, F. Jardin · 2021 · Pharmaceuticals
32. Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence
    Masami Ueda, Tomohiro Iguchi, Takaaki Masuda, Yujiro Nakahara, Hidenari Hirata, Ryutaro Uchi, Atsushi Niida, Kota Momose, Shotaro Sakimura, Kenichi Chiba et al. · 2016 · Oncotarget
33. Clinical indications for, and the future of, circulating tumor cells
    Dominic Himchan Moon, Daniel P. Lindsay, Seungpyo Hong, Andrew Zhuang Wang · 2018 · Advanced Drug Delivery Reviews
34. Hybrid Capture–Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Non–Small Cell Lung Cancer
    Alexa Betzig Schrock, Allison W. Welsh, Jon Chung, Dean C. Pavlick, Eric Bernicker, Ben Creelan, Brady Forcier, Jeffrey S. Ross, Philip J. Stephens, Siraj Mahamed Ali et al. · 2018 · Journal of Thoracic Oncology
35. A novel electrochemical biosensor for sensitive detection of non-small cell lung cancer ctDNA using NG-PEI-COFTAPB-TFPB as sensing platform and Fe-MOF for signal enhancement
    Lei Guo, Zhaode Mu, Bin Yan, Jie Wang, Jing Zhou, Lijuan Bai · 2021 · Sensors and Actuators B Chemical
36. Technical Evaluation of Commercial Mutation Analysis Platforms and Reference Materials for Liquid Biopsy Profiling
    Sabrina Weber, Benjamin Spiegl, Samantha O. Perakis, Christine Ulz, Peter Michael Abuja, Karl Kashofer, Paul van der Leest, Maria L. Aguirre Azpurua, Menno Tamminga, Dan Brudzewsky et al. · 2020 · Cancers
37. Liquid biopsy in lymphoma: Molecular methods and clinical applications
    Melita Cirillo, Alexander F. M. Craig, Sven Borchmann, David M. Kurtz · 2020 · Cancer Treatment Reviews
38. Liquid Biopsy and Artificial Intelligence as Tools to Detect Signatures of Colorectal Malignancies: A Modern Approach in Patient’s Stratification
    Octav Ginghină, Ariana Hudiță, Marius Zamfir, Andrada Spânu, Mara Mardare, Irina Bondoc, Laura Buburuzan, Sergiu Emil Georgescu, Marieta Costache, Carolina Negrei et al. · 2022 · Frontiers in Oncology
39. Minimal residual disease (MRD) detection in solid tumors using circulating tumor DNA: a systematic review
    Lemei Zhu, Ran Xu, Leilei Yang, Wei Shi, Yuan Zhang, Juan Liu, Xi Li, Jun Zhou, Pingping Bing · 2023 · Frontiers in Genetics
40. Non‐invasive detection of genome‐wide somatic copy number alterations by liquid biopsies
    Ellen Heitzer, Peter Ulz, Jochen B. Geigl, Michael R. Speicher · 2015 · Molecular Oncology
41. Alectinib Dose Escalation Reinduces Central Nervous System Responses in Patients with Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer Relapsing on Standard Dose Alectinib
    Justin F. Gainor, Andrew S. Chi, Jennifer Logan, Ranliang Hu, Kevin S. Oh, Priscilla Kaliopi Brastianos, Helen Alice Shih, Alice Tsang Shaw · 2015 · Journal of Thoracic Oncology
42. Circulating Tumor Cells Versus Circulating Tumor DNA in Colorectal Cancer: Pros and Cons
    Carlyn Rose C. Tan, Lanlan Zhou, Wafik S. El‐Deiry · 2016 · Current Colorectal Cancer Reports
43. Targeted single molecule mutation detection with massively parallel sequencing
    Mark Gregory, Jessica A. Bertout, Nolan G. Ericson, Sean D. Taylor, Rithun Mukherjee, Harlan S. Robins, Charles W. Drescher, Jason H. Bielas · 2015 · Nucleic Acids Research
44. Molecular Residual Disease and Adjuvant Trial Design in Solid Tumors
    Maria Frances Coakley, Isaac García-Murillas, Nicholas C. Turner · 2019 · Clinical Cancer Research
45. Liquid Biopsy in Pancreatic Cancer: Are We Ready to Apply It in the Clinical Practice?
    Victoria Heredia-Soto, Nuria Rodrı́guez-Salas, Jaime Feliú · 2021 · Cancers
46. Plasma cell-free RNA profiling distinguishes cancers from pre-malignant conditions in solid and hematologic malignancies
    Breeshey Roskams-Hieter, Hyun Ji Kim, Pavana Anur, Josiah T. Wagner, Rowan L. Callahan, Elias Spiliotopoulos, C. Ward Kirschbaum, Fehmi Çivitçi, Paul T. Spellman, Reid F. Thompson et al. · 2022 · npj Precision Oncology
47. Liquid biopsy on the horizon in immunotherapy of non-small cell lung cancer: current status, challenges, and perspectives
    Ying Yang, Hongyang Liu, Youming Chen, Nan Xiao, Zhaoyang Zheng, Hongchun Liu, Junhu Wan · 2023 · Cell Death and Disease
48. Circulating tumor DNA detection in head and neck cancer: evaluation of two different detection approaches
    Sandra P. Perdomo, Patrice Hodonou Avogbe, Matthieu Foll, Behnoush Abedi‐Ardekani, Violeta Lescher Facciolla, Devasena Anantharaman, Priscilia Chopard, Florence Le Calvez‐Kelm, Marta Vilensky, Jerry Polesel et al. · 2017 · Oncotarget
49. Urine Biopsy—Liquid Gold for Molecular Detection and Surveillance of Bladder Cancer
    Uttam Satyal, Abhishek Srivastava, Philip H. Abbosh · 2019 · Frontiers in Oncology
50. Measuring tumor mutation burden in non-small cell lung cancer: Tissue versus liquid biopsy
    Fenizia, Francesca, Pasquale, Raffaella, Roma, Cristin, Bergantino, Francesca, Iannaccone, Alessia, Normanno, Nicola · 2018 · Translational Lung Cancer Research
51. Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoring
    Yi Chang, Bhairavi Tolani, Xiuhong Nie, Xiuyi Zhi, Mu Hu, Biao He · 2017 · Therapeutics and Clinical Risk Management
52. Urinary Exosomal and cell-free DNA Detects Somatic Mutation and Copy Number Alteration in Urothelial Carcinoma of Bladder
    Dong Hyeon Lee, Hana Yoon, Sanghui Park, Jeong Seon Kim, Young‐Ho Ahn, Kihwan Kwon, Donghwan Lee, Kwang Hyun Kim · 2018 · Scientific Reports
53. Next-Generation Liquid Biopsies: Embracing Data Science in Oncology
    Yu Ri Im, Dana W.Y. Tsui, Luis Alberto Diaz, Jonathan C. M. Wan · 2020 · Trends in cancer
54. Cell-free circulating tumor DNA analysis for breast cancer and its clinical utilization as a biomarker
    Ru Wang, Xiao Li, Huimin Zhang, Ke Wang, Jianjun He · 2017 · Oncotarget
55. Circulating Tumor Cells (CTC) and Cell-Free DNA (cfDNA) Workshop 2016: Scientific Opportunities and Logistics for Cancer Clinical Trial Incorporation
    Lori E. Lowes, Scott Victor Bratman, Ryan Vance Dittamore, Susan J. Done, Shana O. Kelley, Sabine Mai, Ryan D. Morin, Alexander William Wyatt, Alison L. Allan · 2016 · International Journal of Molecular Sciences
56. High efficiency error suppression for accurate detection of low-frequency variants
    Ting-Ting Wang, S. Abelson, J. Zou, Tian-Tian Li, Zhen Zhao, J. Dick, L. Shlush, Trevor J Pugh, S. Bratman · 2019 · Nucleic Acids Research
57. Ultrasensitive DNA hypermethylation detection using plasma for early detection of NSCLC: a study in Chinese patients with very small nodules
    Chen Chen, Xiaojie Huang, Wei Yin, Muyun Peng, Fang Wu, Xia Wu, Jingqun Tang, Mingjiu Chen, Xiang Wang, Alicia Hulbert et al. · 2020 · Clinical Epigenetics
58. Next Generation Sequencing-Based Profiling of Cell Free DNA in Patients with Advanced Non-Small Cell Lung Cancer: Advantages and Pitfalls
    Riziero Esposito Abate, Daniela Frezzetti, Monica Rosaria Maiello, Marianna Gallo, Rosa Camerlingo, Antonella De Luca, Rossella De Cecio, Alessandro Morabito, Nicola Normanno · 2020 · Cancers
59. Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors
    Kevin Chen, Misty Dawn Shields, Pradeep S. Chauhan, Ricardo J. Ramirez, Peter K. W. Harris, Melissa Andrea Reimers, Jose Pedro Zevallos, Andrew A. Davis, Bruna Pellini, Aadel A. Chaudhuri · 2021 · Molecular Diagnosis & Therapy
60. Multiplexed nanomaterial-assisted laser desorption/ionization for pan-cancer diagnosis and classification
    Hua Zhang, Lin Zhao, Jingjing Jiang, Jie Zheng, Li Yang, Yanyan Li, Jian Zhou, Tianshu Liu, Jianmin Xu, Wenhui Lou et al. · 2022 · Nature Communications
61. DREAMing: a simple and ultrasensitive method for assessing intratumor epigenetic heterogeneity directly from liquid biopsies
    Thomas R. Pisanic, Pornpat Athamanolap, Weijie Poh, Chen Chen, Alicia Hulbert, Malcolm V. Brock, James Gordon Herman, Tza‐Huei Wang · 2015 · Nucleic Acids Research
62. Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion
    Hongxia Wang, Nikolas Hendrik Stoecklein, Peter Ping Lin, Olivier Gires · 2016 · Oncotarget
63. Comparison of tumor-informed and tumor-naïve sequencing assays for ctDNA detection in breast cancer
    Santonja, Angela, Cooper, Wendy N, Eldridge, Matthew D, Edwards, Paul A W, Morris, James A, Edwards, Abigail R, Zhao, Hui, Heider, Katrin, Couturier, Dominique‐Laurent, Vijayaraghavan, Aadhitthya et al. · 2023 · EMBO Molecular Medicine
64. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review)
    Alessia Finotti, Matteo Allegretti, Jessica Gasparello, Patrizio Giacomini, Demetrios A. Spandidos, Giuseppe Spoto, Roberto Gambari · 2018 · International Journal of Oncology
65. DISMIR: D eep learning-based noninvasive cancer detection by i ntegrating DNA s equence and methylation information of i ndividual cell-free DNA r eads
    Jiaqi Li, Lei Wei, Xianglin Zhang, Wei Zhang, Haochen Wang, Bixi Zhong, Zhen Xie, Hairong Lv, Xiaowo Wang · 2021 · Briefings in Bioinformatics
66. Circulating and urinary tumour DNA in urothelial carcinoma — upper tract, lower tract and metastatic disease
    Kyle M. Rose, Heather L. Huelster, Joshua J. Meeks, Bishoy M. Faltas, Guru Sonpavde, Seth P. Lerner, Jeffrey S. Ross, Philippe E. Spiess, George Daniel Grass, Rohit Jain et al. · 2023 · Nature Reviews Urology
67. Circulating Cell-Free Nucleic Acids as Epigenetic Biomarkers in Precision Medicine
    Beenish Rahat, Taqveema Ali, Divika Sapehia, Aatish Mahajan, Jyotdeep Kaur · 2020 · Frontiers in Genetics
68. Recent advances in liquid biopsy technologies for cancer biomarker detection
    Narshone Soda, Kimberley Clack, Muhammad J. A. Shiddiky · 2022 · Sensors & Diagnostics
69. The “Liquid Biopsy”: the Role of Circulating DNA and RNA in Central Nervous System Tumors
    Ian David Connolly, Yingmei Li, Melanie Hayden Gephart, Seema Nagpal · 2016 · Current Neurology and Neuroscience Reports
70. Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non‐Small Cell Lung Cancer
    Qingzhu Jia, Lu-Ting Chiu, Shuangxiu Wu, Jian Bai, Lina Peng, Linpeng Zheng, Rui Zang, Xueqin Li, Bibo Yuan, Yixing Gao et al. · 2020 · Advanced Science
71. Simple and Low‐Cost Sampling of Cell‐Free Nucleic Acids from Blood Plasma for Rapid and Sensitive Detection of Circulating Tumor DNA
    Choong Eun Jin, Bonhan Koo, Tae Yoon Lee, Kyudong Han, Seok‐Byung Lim, In Ja Park, Yong Moon Shin · 2018 · Advanced Science
72. Will liquid biopsies improve outcomes for patients with small-cell lung cancer?
    Fiona Helen Blackhall, Kristopher K. Frese, Kathryn Simpson, Elaine Kilgour, Gerard Brady, Caroline Dive · 2018 · The Lancet Oncology
73. Circulating free tumor DNA in non-small cell lung cancer (NSCLC): clinical application and future perspectives
    Guillaume Herbreteau, Audrey Vallée, Sandrine Charpentier, Nicola Normanno, Paul M Hofman, Marc Guillaume Denis · 2019 · Journal of Thoracic Disease
74. Clinical Utility of Liquid Diagnostic Platforms in Non-Small Cell Lung Cancer
    Benjamin Philip Levy, Zishuo I. Hu, Kristen N. Cordova, Sandra L. Close, Karen Lee, Daniel Jacob Becker · 2016 · The Oncologist
75. Correlation between progression‐free survival, tumor burden, and circulating tumor DNA in the initial diagnosis of advanced‐stage EGFR‐mutated non‐small cell lung cancer
    Yunkyoung Lee, Sojung Park, Woo Sung Kim, Jae Cheol Lee, Se Jin Jang, Jene Choi, Chang‐Min Choi · 2018 · Thoracic Cancer
76. The Translational Status of Cancer Liquid Biopsies
    Siniša Bratulić, Francesco Gatto, Jens Nielsen · 2019 · Regenerative Engineering and Translational Medicine
77. Fe–Au Nanoparticle‐Coupling for Ultrasensitive Detections of Circulating Tumor DNA
    Ping Hu, Shengjian Zhang, Tong S. Wu, Dalong Ni, Wenpei Fan, Yan Qing Zhu, Rong Qian, Jianlin Shi · 2018 · Advanced Materials
78. Monitoring KRAS mutations in circulating DNA and tumor cells using digital droplet PCR during treatment of KRAS -mutated lung adenocarcinoma
    Nicolas Marie Guibert, Anne Pradines, Magali Farella, Anne Casanova, Sandrine Gouin, Laura Keller, Gilles Favre, Julien Mazières · 2016 · Lung Cancer
79. Technical Validation of a Next-Generation Sequencing Assay for Detecting Clinically Relevant Levels of Breast Cancer–Related Single-Nucleotide Variants and Copy Number Variants Using Simulated Cell-Free DNA
    Xin Yang, Yuxing Chu, Rui Zhang, Yanxi Han, Lucheng Zhang, Yu Fu, Dan Li, Rongxue Peng, Dongdong Li, Jiansheng Ding et al. · 2017 · Journal of Molecular Diagnostics
80. Genomic approaches to accelerate cancer interception
    Jennifer Beane, Joshua David Campbell, Julian Lel, Jessica L. Vick, Avrum E. Spira · 2017 · The Lancet Oncology
81. Fully automated, on-site isolation of cfDNA from whole blood for cancer therapy monitoring
    Chi‐Ju Kim, Juhee Park, Vijaya Sunkara, Tae-Hyeong Kim, Yongjin Lee, Kyusang Lee, Mi‐Hyun Kim, Yoon‐Kyoung Cho · 2018 · Lab on a Chip
82. Characteristics, properties, and potential applications of circulating cell-free dna in clinical diagnostics: a focus on transplantation
    Karen R. Sherwood, Eric T. Weimer · 2018 · Journal of Immunological Methods
83. Cell‐Free Virus‐Host Chimera DNA From Hepatitis B Virus Integration Sites as a Circulating Biomarker of Hepatocellular Cancer
    Chiao‐Ling Li, Ming‐Chih Ho, You‐Yu Lin, Sheng‐Tai Tzeng, Yun‐Ju Chen, Hsin‐Yung Pai, Ya-Chun Wang, Chi‐Ling Chen, Yu‐Hsin Lee, Ding‐Shinn Chen et al. · 2020 · Hepatology
84. Circulating Tumor DNA–Defined Minimal Residual Disease in Solid Tumors: Opportunities to Accelerate the Development of Adjuvant Therapies
    Arvind N. Dasari, Axel F. Grothey, Scott Kopetz · 2018 · Journal of Clinical Oncology
85. Liquid biopsy: An emerging prognostic and predictive tool in Head and Neck Squamous Cell Carcinoma (HNSCC). Focus on Circulating Tumor Cells (CTCs)
    Panagiota Economopoulou, Ioannis Kotsantis, Efthymios Kyrodimos, Evi S. Lianidou, Amanda K. Psyrri · 2017 · Oral Oncology
86. Computational Cancer Biology: An Evolutionary Perspective
    Niko Beerenwinkel, Chris Greenman, Jens Lagergren · 2016 · PLoS Computational Biology
87. Circulating tumour DNA is a potential biomarker for disease progression and response to targeted therapy in advanced thyroid cancer
    David Allin, Rehanoddin Shaikh, P. Carter, Khin Thway, Mansour T. A. Sharabiani, D.G. de Castro, Ben O’Leary, Isaac García-Murillas, Shreerang A Bhide, Michael J.F. Hubank et al. · 2018 · European Journal of Cancer
88. Circulating tumor DNA detection: A potential tool for colorectal cancer management (Review)
    Huizi Li, Changwen Jing, Jianzhong Wu, Jie Ni, Huanhuan Sha, Xiaoyue Xu, Yuanyuan Du, Rui Lou, Shuchen Dong, Jifeng Feng · 2018 · Oncology Letters
89. Liquid biopsy in pancreatic cancer: the beginning of a new era
    Dipesh Kumar Yadav, Xueli Bai, Rajesh Kumar Yadav, Alina Singh, Guogang Li, Tao Ma, Wei Chen, Tingbo Liang · 2018 · Oncotarget
90. Comparison of variant allele frequency and number of mutant molecules as units of measurement for circulating tumor DNA
    Manouk K. Bos, Kazem Nasserinejad, Maurice P.H.M. Jansen, Christi M. J. Steendam, Lindsay Angus, Peggy N. Atmodimedjo, Evert de Jonge, Winand N.M. Dinjens, Ron H. N. van Schaik, Marzia Del Re et al. · 2020 · Molecular Oncology
91. Role of Exosomal miRNA in Bladder Cancer: A Promising Liquid Biopsy Biomarker
    Xuan‐Mei Piao, Eun‐Jong Cha, Seok Joong Yun, Wun‐Jae Kim · 2021 · International Journal of Molecular Sciences
92. The omics technologies and liquid biopsies: Advantages, limitations, applications
    Daniele Magro, Marika Venezia, Carmela Rita Balistreri · 2024 · Medicine in Omics
93. Liquid biopsy for pediatric diffuse midline glioma: a review of circulating tumor DNA and cerebrospinal fluid tumor DNA
    Tej Deepak Azad, Michael Chuwei Jin, Lydia J. Bernhardt, Chetan Bettegowda · 2020 · Neurosurgical FOCUS
94. Is tissue still the issue in detecting molecular alterations in lung cancer?
    Chong Kin Liam, Sugamya Mallawathantri, Kwun Meng Fong · 2020 · Respirology
95. Sensitive and selective ctDNA detection based on functionalized black phosphorus nanosheets
    Chi Huang, Shushu Hu, Xue Zhang, Haodong Cui, Lie Wu, Na Yang, Wenhua Zhou, Paul Kim-Ho Chu, Xue‐Feng Yu · 2020 · Biosensors and Bioelectronics
96. Comparison of solid tissue sequencing and liquid biopsy accuracy in identification of clinically relevant gene mutations and rearrangements in lung adenocarcinomas
    Lawrence Hsu Lin, Douglas H. R. Allison, Yang Feng, George Jour, Kyung Park, Fang Zhou, Andre Luis Moreira, Guomiao Shen, Xiaojun Feng, Joshua K. Sabari et al. · 2021 · Modern Pathology
97. High‐Performance Nucleic Acid Sensors for Liquid Biopsy Applications
    Jagotamoy Das, Shana O. Kelley · 2019 · Angewandte Chemie
98. Implementing circulating tumor DNA as a prognostic biomarker in resectable non-small cell lung cancer
    Christopher Abbosh, Darren Hodgson, Gary Joseph Doherty, Davina Gillian Gale, James R. Black, Leora Horn, Jorge Sergio Reis-Filho, Charles Swanton · 2024 · Trends in cancer
99. Noninvasive genotyping and monitoring of anaplastic lymphoma kinase (ALK) rearranged non-small cell lung cancer by capture-based next-generation sequencing
    Ye Wang, Pan-wen Tian, Wei-ya Wang, Ke Wang, Zhou Zhang, Bo-Jiang Chen, Yan-Qi He, Lei Li, Hao Liu, Shannon Chuai et al. · 2016 · Oncotarget
100. The Emerging Role of “Liquid Biopsies,” Circulating Tumor Cells, and Circulating Cell-Free Tumor DNA in Lung Cancer Diagnosis and Identification of Resistance Mutations
     Angela Espósito, Carmen Criscitiello, Dario Trapani, Giuseppe Curigliano · 2017 · Current Oncology Reports